发明申请
US20060088823A1 Microarray gene expression profiling in clear cell renal cell carcinoma : prognosis and drug target identification
审中-公开
微阵列基因表达谱在透明细胞肾细胞癌中：预后和药物靶标鉴定
- 专利标题： Microarray gene expression profiling in clear cell renal cell carcinoma : prognosis and drug target identification
- 专利标题（中）： 微阵列基因表达谱在透明细胞肾细胞癌中：预后和药物靶标鉴定
-
申请号： US10473173申请日： 2002-03-29
-
公开(公告)号： US20060088823A1公开(公告)日： 2006-04-27
- 发明人: Brian Haab , Daniel Rhodes , Bin Teh , Masayuki Takahashi
- 申请人： Brian Haab , Daniel Rhodes , Bin Teh , Masayuki Takahashi
- 国际申请： PCT/US02/09576 WO 20020329
- 主分类号： C12Q1/68
- IPC分类号： C12Q1/68
摘要：
A nucleic acid probe or a novel set of such probes in a microarray is provided. The probe or probe set is useful in the prognosis of patients with clear cell renal cell carcinoma (CC-RCC), wherein aggressive and non-agressive CC-RCC tumor types are characterized by differential expression profiles of genes that hybridize with one or more of these probes. Microarrays and kits